Bristol Myers Squibb (BMY) has announced a dividend increase, signaling continued dividend growth for investors. The company's Board of Directors declared a quarterly dividend of $0.63 per share on its common stock, payable February 2, 2026 to holders of record as of January 2, 2026. This represents a 1.6% rise from the prior quarter’s $0.62 per share. If maintained through the year, the annual dividend would be $2.52 per share for fiscal year 2026, assuming the Board continues its normal quarterly reviews.
Additionally, the Board declared a quarterly dividend of $0.50 per share on the company’s $2.00 convertible preferred stock, with a payment date of March 2, 2026 to record holders as of February 3, 2026.
About Bristol Myers Squibb: Transforming Patients’ Lives Through Science
Bristol Myers Squibb aims to discover, develop, and deliver innovative medicines to help patients overcome serious diseases. The company emphasizes bold scientific pursuits to define the future of medicine and patient care. For more information, please visit BMS.com and follow the company on LinkedIn, X, YouTube, Facebook, and Instagram.
Source: Bristol Myers Squibb
Media downloads:
Categories: Press Releases
